Our Mission

The International Ph.D. Program for Cell Therapy and Regeneration Medicine (IPCTRM) begin to recruit students for Fall semester in 2007. The mission of this program is to promote translational medicine and clinical trials of cell/stem cell based therapy. Research at IPCTRM provide diverse research fields, including immune cell applications in cancer treatment; blood and mesenchymal stem cells for regenerative processes, wound healing, graft-versus-host disease, and amyotrophic lateral sclerosis; and drug screening platform with cancer stem cells and disease-specific induced pluripotent stem cells. IPCTRM brings experts and scientists together to facilitate outstanding research not only in basic study  but also emphasis on clinical translational medicine, and industrial cell/stem cell product development.

Program Highlights

ü   Cancer immunotherapy

ü   Pluripotent small blood stem cells

ü   Mesenchymal stem cells

ü   Embryonic germ cells and induced pluripotent stem cells

ü   Drug screening platform with disease iPS cells

ü   FDA/TFDA regulations on cell therapy

ü   CMC/Pharm-Tox/Clinical trial/IRB training